{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"groups":[{"description":"Following total-body irradiation, thiotepa, fludarabine, and muromonab-CD3, participants are given a donor peripheral stem cell transplant and a donor natural killer cell transplant.","id":"OG000","title":"Treatment"}],"populationDescription":"Analysis for this endpoint not feasible due to funding constraint.","reportingStatus":"POSTED","timeFrame":"Up to 5 years","title":"Cytomegalovirus-specific T Cells in Product and Donor Graft","type":"SECONDARY"}